Skip to content

New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population

New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03153865
Acronym
NATIONAL-1
Enrollment
2000
Registered
2017-05-15
Start date
2017-06-02
Completion date
2020-12-31
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment Strategy, Unruptured Cerebral Aneurysm

Brief summary

This is a prospective, multicenter, observational study, aiming at comparing the Safety and effectiveness among the different surgical treatment of unruptured intracranial aneurysms in China, so as to improve the diagnosis and treatment of unruptured intracranial aneurysms.

Interventions

None listed

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients diagnosed with unruptured intracranial saccular aneurysm on CTA, MRA or DSA. * patients willing to participate in this clinical trial and attach to regular follow up.

Exclusion criteria

* intracranial aneurysm correlating to AVM. * intracranial non-saccular aneurysm. * the rupture or unrpture of the aneurysm confirmed on CTA、MRA or DSA. * patients unwilling to participate in this clinical trial and attach to regular follow up.

Design outcomes

Primary

MeasureTime frameDescription
mortality and disabilitythrough study completion, an average of 1 yearthe rate of death and disable

Secondary

MeasureTime frameDescription
recurrence rate1 month, 6 months and 1 year after surgery;
progression of disease1 month, 6 months and 1 year after conservative treatment;enlarge or ruptured of the aneurysm

Other

MeasureTime frameDescription
the level of psychological states changes1 month, 6 months and 1 year after been aware of the diseaseThe Sheet for Affective Disorders was used to record the level of psychological states changes in every participant when they were aware of the disease.

Countries

China

Contacts

Primary ContactPengfei Yang, MD
15921196312@163.com+86 15921196312
Backup ContactHongjian Zhang, MD
chzhanghj2012@me.com+86 13961616656

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026